Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591
Ornstein, 1998, Evaluation and management of men whose radical prostatectomies failed: Results of an international survey, Urology, 52, 1047, 10.1016/S0090-4295(98)00403-8
Pasquier, 2008, Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: A literature review, Int J Radiat Oncol Biol Phys, 72, 972, 10.1016/j.ijrobp.2008.07.026
Stephenson, 2004, Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy, JAMA, 291, 1325, 10.1001/jama.291.11.1325
Choo, 2009, Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse, Int J Radiat Oncol Biol Phys, 75, 983, 10.1016/j.ijrobp.2008.12.049
Pazona, 2005, Salvage radiation therapy for prostate specific antigen progression following radical pros-tatectomy: 10-year outcome estimates, J Urol, 174, 1282, 10.1097/01.ju.0000173911.82467.f9
Buskirk, 2006, Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: Evaluation of prognostic factors and creation of a prognostic scoring system, J Urol, 176, 985, 10.1016/j.juro.2006.04.083
Pisansky, 2000, Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer, J Urol, 163, 845, 10.1016/S0022-5347(05)67817-2
Walsh, 1980, Radical prostatectomy for the treatment of localized prostatic carcinoma, Urol Clin North Am, 7, 583, 10.1016/S0094-0143(21)00146-4
True, 1994, Surgical pathology examination for the prostate gland: Practice survey by the American Society of Clinical Pathologist, Am J Clin Pathol, 102, 572, 10.1093/ajcp/102.5.572
Zudaire, 2000, p53 and Ki67 expression in specimens of radical prostatectomy. Relationship with clinico-pathologic data and survival, Actas Urol Esp, 24, 307
Pacholke, 2004, Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival, Urology, 64, 982, 10.1016/j.urology.2004.06.020
Choo, 2002, (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recur-rence after radical prostatectomy, Int J Radiat Oncol Biol Phys, 53, 269, 10.1016/S0360-3016(02)02730-X
Forman, 1998, Therapeutic radiation in patients with a rising post-prostatectomy PSA level, Oncology, 12, 33
Valicenti, 1998, Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer, Int J Radiat Oncol Biol Phys, 42, 501, 10.1016/S0360-3016(98)00270-3
Cox, 1999, Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy, J Clin Oncol, 17, 1155, 10.1200/JCO.1999.17.4.1155
Grossfeld, 1998, Use of second treatment following definitive local therapy for prostate cancer: Data from the caPSURE database, J Urol, 160, 1398, 10.1016/S0022-5347(01)62548-5
Kalapurakal, 2002, Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy, Int J Radiat Oncol Biol Phys, 54, 1047, 10.1016/S0360-3016(02)03034-1
Brooks, 2005, Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors, J Urol, 174, 2204, 10.1097/01.ju.0000181223.99576.ff
Stephenson, 2007, Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy, J Clin Oncol, 20;25, 2035, 10.1200/JCO.2006.08.9607
Neuhof, 2007, Long term results and predictive factors of three dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy, Int J Radiat Oncol Biol Phys, 67, 1411, 10.1016/j.ijrobp.2006.11.024
Lee, 2005, Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy, J Clin Oncol, 23, 8192, 10.1200/JCO.2005.03.0007
Buskirk, 1996, Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer, Mayo Clin Proc, 71, 242, 10.4065/71.3.242
D’Amico, 1996, An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: Implications on the use of adjuvant therapy, Urology, 47, 538, 10.1016/S0090-4295(99)80492-0
Eggener, 2005, Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy, J Urol, 173, 1150, 10.1097/01.ju.0000155158.79489.48
Algarra, 2013, Actas Urol Esp, Course of the type of patient who is candidate for radical prostatectomy over 2 decades (1989-2009), 37, 347
Smith, 2002, Gleason scores of prostate biopsy and radical prostatectomy specimens over the 10 years: Is there evidence for sustematic upgrading?, Cancer, 94, 2282, 10.1002/cncr.10457
Cooperberg, 2005, The changing face of prostate cancer, J Clin Oncol, 23, 8146, 10.1200/JCO.2005.02.9751
Cooperberg, 2003, Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE), J Urol, 170, S21, 10.1097/01.ju.0000095025.03331.c6
Pollack, 2004, A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy, Int J Radiat Oncol Phys, 60, S186, 10.1016/j.ijrobp.2004.06.120
Crane, 1997, Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation, Int J Radiat Oncol Biol Phys, 39, 681, 10.1016/S0360-3016(97)00361-1
Hayes, 2005, Parameters for treatment decisions for salvage radiation therapy, J Clin Oncol, 23, 8204, 10.1200/JCO.2005.03.1575
Taylor, 2003, Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer, Int J Radiat Oncol Biol Phys, 56, 755, 10.1016/S0360-3016(03)00069-5
Liauw, 2003, Salvage radiotherapy for biochemical failure of radical prostatectomy: A single-institution experience, Urology, 61, 1204, 10.1016/S0090-4295(03)00044-X
Tiguert, 1999, Radiation therapy for a rising PSA level after radical prostatectomy, Semin Urol Oncol, 17, 141
Nudell, 1999, Radiotherapy after radical prostatectomy: Treatment outcomes and failure patterns, Urology, 54, 1049, 10.1016/S0090-4295(99)00299-X
Ward, 2005, Biochemical recurrence after definitive prostate cancer therapy. Part II: Treatment strategies for biochemical recurrence of prostate cancer, Curr Opin Urol, 15, 187, 10.1097/01.mou.0000165553.17534.e3